Genzyme’s Tolevamer Misses Endpoint In First Of Two Phase III Studies
This article was originally published in The Pink Sheet Daily
Executive Summary
“We don’t believe tolevamer will be commercialized in the near future,” Genzyme tells “The Pink Sheet” DAILY.